Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 28Colonic Neoplasms 19Rectal Neoplasms 17Neoplasm Metastasis 15Cholangiocarcinoma 10Stomach Neoplasms 9Liver Neoplasms 4Carcinoma, Hepatocellular 4Neoplasms 3Esophageal Neoplasms 3Pancreatic Neoplasms 2Gastrointestinal Stromal Tumors 2Cirrhosis, Familial, with Pulmonary Hypertension 2Bile Duct Neoplasms 2Appendiceal Neoplasms 2Adenocarcinoma Of Esophagus 2Vipoma 1Somatostatinoma 1Resected Liver Metastases From Colorectal Cancer 1Pseudomyxoma Peritonei 1Pheochromocytoma 1Ovarian Neoplasms 1Neuroblastoma 1Neoplasms, Unknown Primary 1Insulinoma 1Hyperthermia 1Glucagonoma 1Genetic Diseases, Inborn 1Gastrointestinal Neoplasms 1Gastrinoma 1

Interventions

montanide ISA 51 1detox adjuvant 1Ursodeoxycholic Acid 1Surveys and Questionnaires 1Melphalan 1Magnetic Resonance Spectroscopy 1Leucovorin 1Interleukin-2 1Floxuridine 1Diagnostic Tests, Routine 1Celecoxib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Genetic Diseases, Inborn × Floxuridine × Gastrointestinal × Clear all
NCT00019760 2023-10-31

Isolated Hepatic Perfusion With Melphalan Followed By Chemotherapy in Treating Patients With Unresectable Colorectal Cancer That is Metastatic to the Liver

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
Gastrointestinal

Colonic Neoplasms, Gastrointestinal Neoplasms, Carcinoma, Hepatocellular, Neoplasm Metastasis, Neoplasms, Rectal Neoplasms, Colorectal Neoplasms, Genetic Diseases, Inborn

Data powered by HemOnc (CC BY 4.0) Colophon âš¡